Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, Samlali R, Tsoutsou PG, Ozsahin M, Chauvet MP, Turkan S, Boussen H, Kuten A, Tesanovic D, Errihani H, Benna F, Bouzid K, Idbaih A, Mokhtari K, Popovic L, Spano JP, Lotz JP, Cherif A, To H, Kovcin V, Arsovski O, Beslija S, Dzodic R, Markovic I, Vasovic S, Stamatovic L, Radosavljevic D, Radulovic S, Vrbanec D, Sahraoui S, Vasev N, Stojkovski I, Risteski M, Freixa SV, Krengli M, Radosevic N, Mustacchi G, Filipovic M, Kerrou K, Taghian AG, Todorovic V, Geara F, Gligorov J. Belkacemi Y, et al. Among authors: errihani h. Eur J Cancer. 2020 Aug;135:130-146. doi: 10.1016/j.ejca.2020.05.015. Epub 2020 Jun 8. Eur J Cancer. 2020. PMID: 32580130 Free PMC article. Review.
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.
Alsaleh K, Al Zahwahry H, Bounedjar A, Oukkal M, Saadeddine A, Mahfouf H, Bouzid K, Bensalem A, Filali T, Abdel-Razeq H, Larbaoui B, Kandil A, Abulkhair O, Al Foheidi M, Ghosn M, Rasool H, Boussen H, Mezlini A, Haddaoui A, Ayari J, Al Ghamdi M, Errihani H, Abdel-Aziz N, Arafah M, Dabouz F, Bahadoor M, Kullab S, Nabholtz JM; King Saud University, Riyadh, Kingdom of Saudi Arabia, and the International Cancer Research Group (ICRG), Sharjah, Unites Arab Emirates. Alsaleh K, et al. Among authors: errihani h. J Cancer Res Clin Oncol. 2023 Aug;149(9):6171-6179. doi: 10.1007/s00432-023-04588-3. Epub 2023 Jan 21. J Cancer Res Clin Oncol. 2023. PMID: 36680581 Free PMC article. Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Among authors: errihani h. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
[Fever and cancer: components of diagnosis for optimal management].
Moussaid Y, Bertaux M, Chargari C, Helissey C, Le Moulec S, Errihani H, Vedrine L. Moussaid Y, et al. Among authors: errihani h. Rev Med Interne. 2013 Sep;34(9):545-52. doi: 10.1016/j.revmed.2012.10.368. Epub 2012 Nov 27. Rev Med Interne. 2013. PMID: 23199412 Review. French.
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR).
Jazieh AR, Bounedjar A, Abdel-Razeq H, Berna Koksoy E, Ansari J, Tfayli AH, Tashkandi EM, Jastaniah WA, Alorabi MO, Darwish AD, Rabea AM, Al Olayan A, Ibnshamsah F, Errihani H, AlKaiyat MO, Hussain F, Alkattan K, Bruinooge SS, Garrett-Mayer E, Tamim H. Jazieh AR, et al. Among authors: errihani h. J Immunother Precis Oncol. 2024 May 2;7(2):82-88. doi: 10.36401/JIPO-23-38. eCollection 2024 May. J Immunother Precis Oncol. 2024. PMID: 38721403 Free PMC article.
Physical activity in cancer care: barriers and interventions.
Azemmour Y, Boutayeb S, Beddaa H, Errihani H. Azemmour Y, et al. Among authors: errihani h. Pan Afr Med J. 2022 Nov 9;43:131. doi: 10.11604/pamj.2022.43.131.31743. eCollection 2022. Pan Afr Med J. 2022. PMID: 36762161 Free PMC article.
292 results